List of Bulk Drug Substances That May Be Used by an Outsourcing Facility To Compound Drugs for Use in Animals; Request for Nominations; Correction, 36543 [2015-15558]
Download as PDF
<![CDATA[
36543
Federal Register / Vol. 80, No. 122 / Thursday, June 25, 2015 / Notices
reporting on the overall performance of
these grant programs.
Data will be collected from all 60
Community-Centered Healthy Marriage,
54 Pathways to Responsible Fatherhood
and 5 Community-Centered Responsible
Fatherhood Ex-Prisoner Reentry
grantees in the OFA programs. Grantees
will report on program and participant
outcomes in such areas as participants’
improvement in knowledge skills,
attitudes, and behaviors related to
healthy marriage and responsible
fatherhood. Grantees will be asked to
input data for selected outcomes for
activities funded under the grants.
Grantees will extract data from program
records and will report the data twice
yearly through an on-line data
collection tool. Training and assistance
will be provided to grantees to support
this data collection process.
Respondents: Office of Family
Assistance Funded CommunityCentered Healthy Marriage, Pathways to
Responsible Fatherhood and
Community-Centered Responsible
Fatherhood Ex-Prisoner Reentry
Grantees.
ANNUAL BURDEN ESTIMATES
Performance measure reporting form (for private sector affected public) ........................................................................
Performance measure reporting form (for State, local, and
tribal government affected public) ........................................
Estimated Total Annual Burden
Hours: 190
Additional Information:
Copies of the proposed collection may
be obtained by writing to the
Administration for Children and
Families, Office of Planning, Research
and Evaluation, 370 L’Enfant
Promenade SW., Washington, DC 20447,
Attn: ACF Reports Clearance Officer. All
requests should be identified by the title
of the information collection. Email
address: infocollection@acf.hhs.gov.
OMB Comment:
OMB is required to make a decision
concerning the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication. Written comments and
recommendations for the proposed
information collection should be sent
directly to the following: Office of
Management and Budget, Paperwork
Reduction Project, Fax: 202–395–7285,
Email: OIRA_SUBMISSION@
OMB.EOP.GOV, Attn: Desk Officer for
the Administration for Children and
Families.
Robert Sargis,
Reports Clearance Officer.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
[FR Doc. 2015–15547 Filed 6–24–15; 8:45 am]
BILLING CODE 4184–01–P
VerDate Sep<11>2014
16:37 Jun 24, 2015
Jkt 235001
Number of
responses per
respondent
Number of
respondents
Instrument
Average
burden hours
per response
Total annual
burden hours
110
2
0.8
176
9
2
0.8
14
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
document, under Instructions, ‘‘Docket
No. FDA–2013–N–1524’’ is corrected to
read ‘‘Docket No. FDA–2015–N–1196’’.
Dated: June 18, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[Docket No. FDA–2015–N–1196]
List of Bulk Drug Substances That May
Be Used by an Outsourcing Facility To
Compound Drugs for Use in Animals;
Request for Nominations; Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; correction.
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
The Food and Drug
Administration is correcting a notice
entitled ‘‘List of Bulk Drug Substances
That May Be Used by an Outsourcing
Facility to Compound Drugs for Use in
Animals; Request for Nominations’’ that
appeared in the Federal Register of May
19, 2015 (80 FR 28622). The document
announced the intention to develop a
list of bulk drug substances that may be
used by outsourcing facilities registered
under the Federal Food, Drug, and
Cosmetic Act (the FD&C Act) to
compound animal drugs, in accordance
with FDA’s draft guidance for industry
#230, ‘‘Compounding Animal Drugs
from Bulk Drug Substances.’’ The
document was published with an
incorrect docket number. This
document corrects that error.
FOR FURTHER INFORMATION CONTACT: Lisa
Granger, Office of Policy and Planning,
Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 32, rm.
3330, Silver Spring, MD 20993–0002,
301–796–9115.
SUPPLEMENTARY INFORMATION: In the
Federal Register of Tuesday, May 19,
2015, in FR Doc. 2015–11983, the
following correction is made:
1. On page 28622, in the second
column, in the ADDRESSES section of the
SUMMARY:
[FR Doc. 2015–15558 Filed 6–24–15; 8:45 am]
[Docket No. FDA–2011–N–0915]
Agency Information Collection
Activities; Proposed Collection;
Submission for Office of Management
and Budget Review; Guidance for
Industry on Postmarketing Adverse
Event Reporting for Nonprescription
Human Drug Products Marketed
Without an Approved Application
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by July 27,
2015.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
SUMMARY:
E:\FR\FM\25JNN1.SGM
25JNN1
]]>Agencies
[Federal Register Volume 80, Number 122 (Thursday, June 25, 2015)]
[Notices]
[Page 36543]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-15558]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2015-N-1196]
List of Bulk Drug Substances That May Be Used by an Outsourcing
Facility To Compound Drugs for Use in Animals; Request for Nominations;
Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration is correcting a notice
entitled ``List of Bulk Drug Substances That May Be Used by an
Outsourcing Facility to Compound Drugs for Use in Animals; Request for
Nominations'' that appeared in the Federal Register of May 19, 2015 (80
FR 28622). The document announced the intention to develop a list of
bulk drug substances that may be used by outsourcing facilities
registered under the Federal Food, Drug, and Cosmetic Act (the FD&C
Act) to compound animal drugs, in accordance with FDA's draft guidance
for industry #230, ``Compounding Animal Drugs from Bulk Drug
Substances.'' The document was published with an incorrect docket
number. This document corrects that error.
FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy and
Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg.
32, rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115.
SUPPLEMENTARY INFORMATION: In the Federal Register of Tuesday, May 19,
2015, in FR Doc. 2015-11983, the following correction is made:
1. On page 28622, in the second column, in the ADDRESSES section of
the document, under Instructions, ``Docket No. FDA-2013-N-1524'' is
corrected to read ``Docket No. FDA-2015-N-1196''.
Dated: June 18, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-15558 Filed 6-24-15; 8:45 am]
BILLING CODE 4164-01-P
